Phase
Condition
Meningitis
Fungal Infections
Systemic Fungal Infections
Treatment
N/AClinical Study ID
Ages 18-99 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
Patients
Patients must:
- Have cryptococcosis as determined by information collected from their medicalrecords, telephone interviews, or from a referring physician:
histopathology showing cryptococci; or
culture of C. neoformans or C. gattii
a positive cryptococcal antigen in the serum and/or CSF, together with CSF cellcount and chemistry consistent with cryptococcal meningitis.
Be over the age of 18 years old.
Have a primary physician outside of the NIH.
Agree to undergo genetic testing that will include WES and high density SNP arraysas appropriate for possible WES linkage studies.
Allow samples to be stored for future research.
Pregnant patients will not be excluded. However, research procedures greater thanminimal risk including bone marrow biopsy and apheresis would not be performed onpregnant subjects. Otherwise, pregnant patients with cryptococcus would be treatedwith as per standard of care, minimizing teratogenic potential of drugs and ionizingradiation whenever possible.
Blood Relatives of Patients
Blood relatives must:
Be a genetic relative of a patient enrolled in this study
Be over the age of 18 years old
Agree to undergo genetic testing that may include WES and high density SNP analysis
Allow samples to be stored for future research
Healthy Volunteers
Healthy volunteers must:
Be between the ages of 18 and 70 years old
Allow samples to be stored for future research
Exclusion
EXCLUSION CRITERIA:
Patients
Patients will be excluded for any of the following:
- The presence of certain types of acquired abnormalities of immunity due to:
HIV
Cancer chemotherapeutic agent(s)
An underlying malignancy could be grounds for possible exclusion of a patientif, in the opinion of the investigator, the underlying disease predisposed thepatient to the infection
Monoclonal antibody therapy directed against a patient s immune system
- Any condition that in the opinion of the investigator may interfere with theevaluation of a co-existing abnormality of immunity that is the subject of studyunder this protocol. For example, we may exclude patients with Cushing s diseasethat have very high cortisol levels at the time of diagnosis of theircryptococcosis.
Genetic Relatives of Patients
Genetic relatives will be excluded for the following:
-Any condition that in the opinion of the investigator may interfere with evaluation of an immune system abnormality that is the subject of study under this protocol.
Healthy Volunteers
Healthy volunteers will be excluded for any of the following:
HIV or viral hepatitis (B or C).
History of recurrent or severe infections.
History of intravenous drug use.
History of engaging in high-risk activities for exposure to HIV.
Receiving chemotherapeutic agent(s), immunosuppressants or have underlyingmalignancy.
Pregnancy.
Have history of heart, lung, kidney disease, or bleeding disorders.
Any condition that in the opinion of the investigator may interfere with evaluationof an immune system abnormality that is the subject of study under this protocol.
Study Design
Study Description
Connect with a study center
National Institutes of Health Clinical Center
Bethesda, Maryland 20892
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.